Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2018
Dec. 31, 2017
Current Assets:    
Cash $ 9,946,654 $ 185,151
Accounts receivable and other receivables, net 207,082 227,918
Inventory, net 230,730 247,466
Prepaid expenses and other current assets 831,003 108,352
Total Current Assets 11,215,469 768,887
Fixed assets, net 337,238 376,920
Intangible assets, net 103,588 106,167
Deferred public offering costs 1,367,730
Other assets 44,512 67,309
Total Assets 11,700,807 2,687,013
Current Liabilities:    
Accounts payable 1,599,798 4,228,073
Accrued expenses 3,402,922 23,135,344
Accrued issuable equity 3,289,334 2,939,906
Derivative liabilities 21,434 3,448,390
Current portion of convertible notes payable 50,000
Convertible notes payable - related party 747,567
Notes payable 337,966 597,966
Current portion of deferred revenue 351,258 383,771
Total Current Liabilities 9,002,712 35,531,017
Convertible notes payable, non-current portion, net of debt discount of $0, $499,435 and $0 as of March 31, 2018, December 31, 2017 and Pro Forma March 31, 2018, respectively 3,200,096
Deferred revenue, non-current portion 38,867 50,283
Total Liabilities 9,041,579 38,781,396
Series B Convertible Preferred Stock, 10,000 shares designated, 0, 8,250 and 0 shares issued and outstanding as of March 31, 2018, December 31, 2017 and Pro Forma March 31, 2018, respectively 825,000
Commitments and contingencies  
Stockholders' Equity (Deficiency):    
Common stock, $0.001 par value, 500,000,000 shares authorized, 22,181,901 and 5,523,673 shares issued and outstanding as of March 31, 2018 and December 31, 2017, respectively 22,182 5,524
Additional paid-in capital 156,868,224 119,499,141
Accumulated deficit (154,231,190) (156,435,278)
Total Stockholders' Equity (Deficiency) 2,659,228 (36,919,383)
Total Liabilities and Stockholders' Equity (Deficiency) 11,700,807 2,687,013
Series A Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency):    
Preferred stock, $0.001 par value, 40,000,000 shares authorized; 11,000
Series C Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency):    
Preferred stock, $0.001 par value, 40,000,000 shares authorized; 230
Series D Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency):    
Preferred stock, $0.001 par value, 40,000,000 shares authorized; 12
Pro Forma [Member]    
Current Assets:    
Cash 13,532,915  
Accounts receivable and other receivables, net 207,082  
Inventory, net 230,730  
Prepaid expenses and other current assets 831,003  
Total Current Assets 14,801,730  
Fixed assets, net 337,238  
Intangible assets, net 103,588  
Deferred public offering costs  
Other assets 44,512  
Total Assets 15,287,068  
Current Liabilities:    
Accounts payable 1,599,798  
Accrued expenses 2,919,302  
Accrued issuable equity 1,083,904  
Derivative liabilities 21,434  
Current portion of convertible notes payable  
Convertible notes payable - related party  
Notes payable 337,966  
Current portion of deferred revenue 351,258  
Total Current Liabilities 6,313,662  
Convertible notes payable, non-current portion, net of debt discount of $0, $499,435 and $0 as of March 31, 2018, December 31, 2017 and Pro Forma March 31, 2018, respectively  
Deferred revenue, non-current portion 38,867  
Total Liabilities 6,352,529  
Stockholders' Equity (Deficiency):    
Common stock, $0.001 par value, 500,000,000 shares authorized, 22,181,901 and 5,523,673 shares issued and outstanding as of March 31, 2018 and December 31, 2017, respectively 21,623  
Additional paid-in capital 163,144,098  
Accumulated deficit (154,231,190)  
Total Stockholders' Equity (Deficiency) 8,934,539  
Total Liabilities and Stockholders' Equity (Deficiency) 15,287,068  
Pro Forma [Member] | Series A Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency):    
Preferred stock, $0.001 par value, 40,000,000 shares authorized;  
Pro Forma [Member] | Series C Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency):    
Preferred stock, $0.001 par value, 40,000,000 shares authorized;  
Pro Forma [Member] | Series D Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency):    
Preferred stock, $0.001 par value, 40,000,000 shares authorized; $ 8